Related Experiment Videos
[Effectiveness of the new Soviet immunomodulator mielopid in the combined treatment of patients with chronic
Vestnik Dermatologii I Venerologii
|January 1, 1989
Abstract:
Thirty-four patients with chronic pyoderma have been examined. Fifteen of these have been treated with mielopid (18 mg per course). Immunologic and clinical examinations carried out in 3-10 months after therapy have demonstrated a wide-spectrum immunostimulating action of the new drug.